Residual cancer burden index
The residual cancer burden (RCB) index measures the amount of cancer remaining in the breast and nearby lymph nodes after neoadjuvant therapy (treatment given before surgery). The index is used for the most common types of breast cancer, including invasive ductal carcinoma, invasive lobular carcinoma, invasive apocrine carcinoma, and invasive breast carcinoma (not otherwise specified). The index combines several pathologic …
Read More »
